Medios AG (XETRA:ILM1) — Market Cap & Net Worth
Market Cap & Net Worth: Medios AG (ILM1)
Medios AG (XETRA:ILM1) has a market capitalization of $312.19 Million (€267.03 Million) as of August 1, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #14474 globally and #1453 in its home market, demonstrating a -12.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medios AG's stock price €10.98 by its total outstanding shares 25505723 (25.51 Million). See Medios AG (ILM1) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Medios AG Market Cap History: 2016 to 2026
Medios AG's market capitalization history from 2016 to 2026. Data shows growth from $232.59 Million to $327.41 Million (4.01% CAGR).
Medios AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medios AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.21x
Medios AG's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
28.10x
Medios AG's market cap is 28.10 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $232.59 Million | $133.21 Million | -$3.17 Million | 1.75x | N/A |
| 2017 | $582.96 Million | $253.64 Million | $4.13 Million | 2.30x | 141.00x |
| 2018 | $402.55 Million | $327.83 Million | $4.33 Million | 1.23x | 93.04x |
| 2019 | $787.22 Million | $516.80 Million | $9.76 Million | 1.52x | 80.66x |
| 2020 | $1.12 Billion | $626.54 Million | $5.53 Million | 1.78x | 201.85x |
| 2021 | $1.16 Billion | $1.36 Billion | $7.40 Million | 0.85x | 156.51x |
| 2022 | $521.83 Million | $1.61 Billion | $18.33 Million | 0.32x | 28.47x |
| 2023 | $472.93 Million | $1.78 Billion | $18.81 Million | 0.26x | 25.14x |
| 2024 | $394.21 Million | $1.88 Billion | $12.55 Million | 0.21x | 31.42x |
| 2025 | $431.78 Million | $2.08 Billion | $15.37 Million | 0.21x | 28.10x |
Competitor Companies of ILM1 by Market Capitalization
Companies near Medios AG in the global market cap rankings as of August 1, 2026.
Key companies related to Medios AG by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #272 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #525 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #624 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1092 globally with a market cap of $24.01 Billion USD ( AU$33.94 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #272 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $856.19 |
| #525 | Cencora Inc. | NYSE:COR | $50.53 Billion | $311.34 |
| #624 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $230.03 |
| #1092 | Sigma Healthcare Ltd | AU:SIG | $24.01 Billion | AU$2.94 |
Medios AG Historical Marketcap From 2016 to 2026
Between 2016 and today, Medios AG's market cap moved from $232.59 Million to $ 327.41 Million, with a yearly change of 4.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €327.41 Million | -24.17% |
| 2025 | €431.78 Million | +9.53% |
| 2024 | €394.21 Million | -16.65% |
| 2023 | €472.93 Million | -9.37% |
| 2022 | €521.83 Million | -54.95% |
| 2021 | €1.16 Billion | +3.88% |
| 2020 | €1.12 Billion | +41.67% |
| 2019 | €787.22 Million | +95.56% |
| 2018 | €402.55 Million | -30.95% |
| 2017 | €582.96 Million | +150.64% |
| 2016 | €232.59 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Medios AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $312.19 Million USD |
| MoneyControl | $312.19 Million USD |
| MarketWatch | $312.19 Million USD |
| marketcap.company | $312.19 Million USD |
| Reuters | $312.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and p… Read more